cephalosporin + clindamycin + vancomycin

This is a combination of three antibiotics—cephalosporin, clindamycin, and vancomycin—used together for the treatment of severe or complicated bacterial infections where broad-spectrum coverage is required. - **Cephalosporins** are beta-lactam antibiotics that inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to cell lysis and death. They are effective against many gram-positive and some gram-negative bacteria[6]. - **Clindamycin** is a lincosamide antibiotic that inhibits protein synthesis by binding to the 50S ribosomal subunit of susceptible bacteria. It is particularly useful for anaerobic infections and toxin suppression in severe streptococcal or staphylococcal infections[6]. - **Vancomycin** is a glycopeptide antibiotic that inhibits bacterial cell wall assembly by binding to D-Ala-D-Ala termini of cell wall precursor units. It is primarily used for serious gram-positive infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA)[2][3]. This combination may be used empirically in critically ill patients with suspected polymicrobial infection or when both MRSA and anaerobic coverage are needed (e.g., necrotizing fasciitis, toxic shock syndrome)[3][6].